Rating History for Turning Point Therapeutics Inc. (TPTX) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/13/2022 | Michael Schmidt | Downgrade | Neutral (Buy) |
76.00 (N/A) |
74.47 (76.01) |
2.07% | Details |
 |
|||||||
|
|||||||
|
|||||||
